Target intelligence / Profile preview

Norovirus virus-like particle (NoV VLP)

Target
NoV VLP
Molecular classification
Other (virus-like particle), Viral structural protein assembly (capsid mimic)
01

Overview

Norovirus virus-like particles are self-assembled structures composed primarily of the major capsid protein VP1 from noroviruses. These particles closely mimic the morphology and antigenicity of native noroviruses but lack viral genetic material, making them non-infectious. The VP1 protein forms icosahedral shells with T=3 symmetry, consisting of 180 copies arranged as 90 dimers. Each VP1 monomer has two domains: a shell domain that forms the structural core and a protruding domain involved in receptor binding, strain diversity, and immunogenicity. Virus-like particles are widely used in research to study immune responses to noroviruses, develop diagnostic assays, and serve as platforms for candidate vaccines because they present relevant epitopes without risk of causing disease. They do not function as receptors or enzymes themselves; rather, they are tools that simulate the external features of actual viruses. Note on correctness: "Norovirus virus-like particles" is not a canonical therapeutic target such as a receptor or enzyme. Instead, it refers to recombinant assemblies used mainly for research purposes—particularly vaccine development or serology—not direct drug targeting or modulation. Thus "is_target" should be set to false; "is_incorrect" should be true if you require only bona fide molecular targets like receptors or enzymes per your conventions above.

Other names
Norovirus VLPHuman norovirus virus-like particleNoV-VLPNorwalk virus-like particle
02

Biological functions

Antigen presentation (as immunogen in research and vaccine development)Mimicry of native virion structure for serological assays and immunogenicity studies
03

Disease associations

Infection (used as a model for norovirus infection, but not itself infectious)Other (tool for vaccine development and diagnostics)
04

Safety considerations

Not infectious, but may elicit immune response as an antigenUsed in research settings; no known direct therapeutic safety concerns since it is non-infectious

Beyond the preview

Go deeper on Norovirus virus-like particle (NoV VLP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Norovirus virus-like particle (NoV VLP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call